Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 18:22 (1564 d 09:00 ago) – Posting: # 20812
Views: 4,812

❝ Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.


And all this at the moment is a offense against the law.

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,636 registered users;
26 visitors (0 registered, 26 guests [including 6 identified bots]).
Forum time: 03:22 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5